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Depression At a group level, transcranial random noise stimulation (tRNS) over bilateral dorsolateral prefrontal
cortex did not significantly improve mood across participants.
 Individual differences in age and trait mood affect the direction of mood change in response to tRNS.
 Mood change was comparable in older adults with and without cardiovascular risk factors.
a b s t r a c t
Objectives: To assess whether changes in brain microstructures associated with ageing and presence of
cardiovascular risk factors (CVRF) reduce the efficacy of transcranial electrical stimulation (tES) improv-
ing mood in euthymic older adults.
Methods: Using excitatory high-frequency transcranial random noise stimulation (tRNS) over bilateral
dorsolateral prefrontal cortex, the effect on mood was assessed in euthymic young adults (YA), older
adults (HOA) and older adults with CVRF (OVR). Active-tRNS or sham was applied over two sessions.
Positive and Negative Affect Schedule and Warwick Edinburgh Mental Well-being Scale measured self-
reported state mood before and after stimulation. Trait mood was also measured using the Geriatric
Depression Scale.
Results: Response to tRNS seemed dependent on individual differences in age and trait mood. In HOA,
more negative trait mood was associated with more positive mood change after tRNS. OVR showed a sim-
ilar but reduced pattern of mood change to HOA. In YA, more positive trait mood was associated with
greater positive mood change after tRNS.
Conclusions: Age and trait mood may be important factors when examining the efficacy of tES as an alter-
native treatment for depression.
Significance: Future studies should consider how response to tES is affected by individual differences.
 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Major depressive disorder (MDD) is common among otherwise
healthy older adults, occurring inmore than 13% of individuals over
60 years old (Beekman et al., 1999). Despite this, less than a quarter
of older adults with depression receive treatment (Roose and
Schatzberg, 2005). Older adults diagnosedwithMDDmay be refrac-
tory to treatment, reluctant to start drug therapies and have resid-
ual cognitive difficulties even when depression symptoms abate
(Alexopoulos, 2005; Barch et al., 2012). Beyond MDD, 15% of olderadults are estimated to have sub-clinical levels of depression and
persistent low mood (dysthymia) that impairs quality of life and
is associated with poor cognitive performance (Barch et al., 2012).
Given the ageing population and prevalence of dysthymia, alternate
therapies for MDD and dysthymia is vital. Transcranial electrical
stimulation (tES), a non-invasive method where a weak electrical
current is applied to the head to excite or inhibit neural activity
(Jorge and Robinson, 2011) may be an alternative to standard treat-
ments. Preliminary evidence suggests that tES may improve mood
in young adulthood but its efficacy among older adults has not been
examined. This study will examine the effects of tES on mood in
euthymic younger and older adults.
Studies exploring the effects of tES have predominantly used
transcranial direct current stimulation (tDCS; tES where a direct
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dorsolateral prefrontal cortex (DLPFC) can improve mood in young
adults with and without MDD (Boggio et al., 2008; Brunoni et al.,
2014; Ferrucci et al., 2009). The left DLPFC is often targeted for
active tES as it may be hypoactive in MDD (Grimm et al., 2008;
Koenigs and Grafman, 2009). In young adults with MDD, tDCS of
the left DLPFC resulted in reduced depression ratings (Boggio
et al., 2008). Among adults with MDD (18–65 years), Brunoni and
colleagues (Brunoni et al., 2014) demonstrated a reduction in
depressive symptoms (immediately after treatment and at two-
week follow-up) when bilateral DLPFC tDCS was applied while a
working memory task was performed over 10 sessions. Positive
effects of left DLPFC stimulation have been reported in healthy par-
ticipants, where stimulation facilitated cognitive reappraisal
(Feeser et al., 2014) and reduced self-reported emotional distress
when viewing aversive stimuli (Boggio et al., 2009). TES has not
yet been applied to elevate mood in older adults either with or
without MDD.
Whilst tES shows promise, research suggests its effects on mood
or cognition may vary depending on the individual. These findings
warrant the need to assess whether the effects of tES may differ in
late-life compared to young adulthood. Although tES has not yet
been applied in a systematic fashion to effect mood in ageing,
one case report has been identified. In a 92-year-old-patient with
MDD, improved mood was demonstrated after 10 sessions of tDCS
to the left DLPFC (Shiozawa et al., 2014a). Further studies have
used a different brain stimulation technique, transcranial magnetic
stimulation (TMS). TMS uses a rapidly changing magnetic field to
temporarily modulate the function of the targeted cortical area
(Pascual-Leone et al., 1999). High-frequency repetitive TMS (rTMS)
to the left DLPFC can enhance excitability, resulting in improved
mood in young adults (Jorge and Robinson, 2011) and older adults
with vascular depression (Jorge et al., 2008). However other rTMS
studies have shown an inconsistent or absence of any antidepres-
sant effects (Manes et al., 2001; Mosimann et al., 2004) and the
efficacy of tDCS has not been established. As such, while brain
stimulation may be effective in treating depression, its role as an
alternative therapy is yet to be established (Berlim et al., 2013;
Slotema et al., 2010).
Differences across study findings corroborate the suggestion
that the efficacy of tES may be partly dependent on individual dif-
ferences within different populations. Further, whilst TMS has high
spatial and temporal frequency, it is expensive and difficult to
apply. In contrast tES produces lasting after-effects on behaviour,
is safe, inexpensive and easy to apply (Kadosh, 2013; Nitsche and
Paulus, 2011). When tDCS has been applied with older adults it
has primarily been with the aim of improving cognition (Meinzer
et al., 2013), where DLPFC stimulation has improved executive
function (Berryhill and Jones, 2012; Zimerman and Hummel,
2010). Although the optimal stimulation protocol for improvement
is not yet clear, these studies suggest that tES may be an effective
intervention in ageing, and has potential as a therapeutic tech-
nique in late-life depression (Jorge and Robinson, 2011).
Though tDCS to target a specific site may be optimal for young
adults where unilateral neural networks are well understood, it
may be less effective for older adults where differences in func-
tional networks have been observed (Cabeza, 2002). When young
adults typically recruit unilateral brain regions to complete a task,
older adults often demonstrate reduced task-specific hemispheric
asymmetry and rely on bilateral activation (Cabeza, 2002;
Zimerman and Hummel, 2010). This bilateral activity in older
adults has been hypothesised to be compensatory, as it is associ-
ated with better task performance compared to older adults who
demonstrate unilateral activation, and results in equivalent perfor-
mance to young adults who show unilateral activity (Cabeza,
2002). These network changes have been linked to age-related dif-ferences in response to tDCS where, unlike younger adults, older
adults have shown a reversed pattern of response, or behavioural
effects after homologous regions in the contralateral hemisphere
were stimulated (Ross et al., 2011; Zimerman and Hummel,
2010). Therefore unilateral tDCS stimulation may be less effective
in older adults. Unlike tDCS, transcranial random noise stimulation
(tRNS) is not constrained by current flow direction and provides
excitation at both electrode sites (Terney et al., 2008), which may
be more effective with older adults who rely on bilateral activity.
Recent studies have also suggested that tRNS demonstrated stron-
ger effects than tDCS including a case of MDD where greater symp-
tom reduction was reported after tRNS compared to tDCS (Chan
et al., 2012; Fertonani et al., 2011). Further, tRNS may provoke
fewer cutaneous effects (e.g. itching sensation) than tDCS, making
it appropriate for studies where participants receive both active
and sham tES (Ambrus et al., 2010). This is particularly important
in studies of self-reported mood where there is risk of placebo
effects. The efficacy of high-frequency tRNS to modulate mood
across the lifespan remains an important question that has not
yet been explored.
Cardiovascular risk factors (CVRF) such as high-blood pressure
or diabetes which lead to cardiovascular damage in the brain, are
common in ageing (Kennedy and Raz, 2009; Knopman et al.,
2011; Raz et al., 2007) and may also influence the efficacy of tES.
CVRF have been shown to disrupt white matter microstructure
that support neural networks involved in cognition and mood reg-
ulation (Alexopoulos, 2005; Taylor et al., 2013; Kennedy and Raz,
2009; Verdelho et al., 2007). Age-related disruption in white mat-
ter microstructure has been demonstrated throughout the brain
but particularly in anterior regions including the DLPFC where
degradation is associated with late-life depression (Bae et al.,
2006; O’Sullivan et al., 2001). It is not yet clear whether cardiovas-
cular damage to white matter may further influence the efficacy of
tES or the spread of stimulation across the affected neural net-
works in older adults. Therefore the current study will also exam-
ine CVRF and its impact on response to tES.
In this study we examine the efficacy of tRNS applied bilaterally
to the DLPFC (implicated in mood regulation by previous research)
to improve mood in older euthymic adults with and without CVRF,
and young adults. Participants received both active and sham tRNS
using a double-blind design; presence of CVRF among older adults
was measured. We hypothesised that: (1) tRNS may be as effective
in older compared to younger euthymic adults and (2) that efficacy
of tRNS among older adults would be associated with fewer CVRF.
We also sought to explore whether individual differences in trait
mood levels (i.e. long-term mood characteristics) influences
response to tRNS.2. Methods
2.1. Participants and procedure
Participants: recruitment was conducted through community
outreach and local newspaper advertising. Exclusion criteria
included any contraindications to tRNS (Rossi et al., 2009) and cur-
rent or recent history of depression, presence of psychiatric or neu-
rological conditions. These criteria minimised the variance in
baseline cortical excitability introduced by psychological or psy-
chiatric problems, which can moderate and potentially reverse
the anticipated excitatory effect of tES (Krause and Cohen
Kadosh, 2014). Furthermore, since the efficacy of tES has not yet
been established, an initial study on euthymic individuals was
deemed a necessary step prior to interventions with patients,
which may have negative effects. Ten people were excluded from
the study at initial screening (current/recent history of depression
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bility n = 1). Sixty older adults aged over 60 years (Mage = 67.33 ±
6.7, 25 male) and 30 younger adults (YA) aged 20–40 years
(Mage = 26.37 ± 5.3, 14 male) participated. Older adults (OA) were
divided into two groups, healthy older adults (HOA) and older
adults with CVRF (OVR). OVR had a diagnosis of hypertension, dia-
betes, or had a high average blood pressure reading (>140 systolic
and/or >90 diastolic) at the time of testing. A modified version of
the Framingham Stroke Risk Profile excluding age as a risk factor
(FSRP;Wolf et al., 1991) was recorded to quantify CVRF. See Table 1
for demographic information. All participants gave written
informed consent and were given an honorarium of up to £40 for
taking part. The study was approved by Goldsmiths University of
London Ethics committee.
2.2. Assessment
Background Measures: depressive symptoms were measured
using the Geriatric Depression Scale (GDS; Yesavage, 1988) in both
sessions of the study; GDS scores quantified trait mood whereby a
higher score indicated lower trait mood. The scale was adminis-
tered to all participant groups as it has been shown to be appropri-
ate for use with young adults (Weintraub et al., 2007). Whilst trait
mood was expected to be stable, the GDS was measured in both
sessions to rule out any anomalous changes in mood. The Mini-
mental state exam (MMSE; Molloy et al., 1997) was used as a
screen for cognitive impairment across participants (at risk <24);
all participants scored above this cut-off (see Table 1). The Wech-
sler Test of Adult Reading (WTAR; Wechsler, 2001) was used to
estimate full-scale IQ (FSIQ).
Experimental Measures: in both sessions, participants completed
the Positive and Negative Affect Schedule (PANAS; Watson et al.,
1988) and Warwick-Edinburgh Mental Well-being Scale
(WEMWBS; Tennant et al., 2007) before and after stimulation
(active-tRNS/sham). Participants completed each questionnaire in
relation to how they felt at that moment in time to quantify cur-
rent mood state. These scores were used to quantify mood change
due to tRNS. Scores on the PANAS-negative affect were low and lit-
tle variance was observed. Due to suspected floor effects, this mea-
sure was not used in the analysis. For both PANAS-positive affect
and WEMWBS higher scores indicate more positive mood.
2.3. Transcranial random noise stimulation (tRNS)
After completing the mood questionnaires, stimulation was
applied using a DC-Stimulator Plus device (neuroConn, Germany).
During active-tRNS, 1 mA of high-frequency stimulation was
applied for 10 min. The duration of after effects were unknown,
yet based on previous research were anticipated to be shorter than
the 60 min observed when targeting the motor cortex (Nitsche and
Paulus, 2011). Two 5  5 cm (25 cm2) rubber electrodes wereTable 1
Demographics for each participant group, mean (standard deviation).
Demographics YA (n = 28) HOA (n = 28) OV
Sex (M:F) 13:15 11:17 13:
Age 26.68 (5.4) 67.43 (7.0) 66.
Education levela 4.50 (1.2) 4.36 (1.8) 3.7
Trait Mood (GDS) 5.32 (3.5) 2.71 (3.2) 4.3
MMSE 29.57 (0.7) 29.14 (1.3) 29.
FSRP(%)No Age 1.79 (1.3) 1.83 (1.0) 4.1
WTAR FSIQ 109.89 (6.6) 111.50 (5.8) 109
* p < .05.
*** p < .001. –: comparable between groups; <: significant difference between adjacent
a Education level coding: 0 = no qualification; 1 = GCSE/NVQ (16 yrs); 2 = City & Guilds
= Degree; 6 = Masters; 7 = PhD.encased in saline-soaked sponges and positioned bilaterally over
the DLPFC (identified using F3 and F4 based on the 10-20 system
as per previous studies (Boggio et al., 2008; Brunoni et al., 2014;
Shiozawa et al., 2014b). Stimulation was ramped up and down
for 15 s at the beginning and end of stimulation. During sham,
the current was applied for 30 s after ramping up before switching
off. Such a short duration of tRNS has been shown to have no effect
on cortical excitability (Ambrus et al., 2010; Kadosh, 2013) and to
be indistinguishable from active-tRNS (Ambrus et al., 2010;
Kadosh, 2013).
2.4. Procedure
All participants attended two sessions where they received
active-tRNS or sham stimulation using a double-blind procedure.
Sessions were between 2 and 14 days apart (M = 5.9 days ± 4.2).
Stimulation type (active-tRNS/sham) was randomised and coun-
terbalanced across participants. In the first session participants
were given a brief interview to assess the presence of any CVRF
and completed the cognitive tests. Participants also identified
two positive memories, one of which would be recalled and
described to the researcher in each session. In both sessions, partic-
ipants completed the GDS to describe trait mood followed by the
pre-stimulation PANAS and WEMWBS describing state mood. Dur-
ing the first five minutes of stimulation participants sat quietly and
for the remaining five minutes participants described one of the
identified positive memories in order to induce a more positive
mood. Immediately after stimulation, participants completed the
post-stimulation PANAS and WEMWBS.
2.5. Data analysis
As presence of depression was an exclusion criterion for the
study, GDS scores were reviewed. One YA was removed from the
analyses having scored 23 (severe depression) on the GDS. Among
the remaining participants a maximum of 15/30 was recorded on
the GDS (criteria for mild depression score 10) with an average
score of 4.13 (SD = 3.87). Grubbs’ test (Grubbs, 1969) for outliers
on Mood Change identified three participants (two HOA; one YA)
as outliers who were removed from the analyses. As GDS scores
were not normally distributed (Shapiro-Wilk(86) = .864, p < .001)
they were converted into z scores for use in the analyses. This
was expected due to our exclusion criteria. Group differences in
demographic variables were analysed using ANOVA or Chi-
Square as appropriate.
The effect of stimulation (active-tRNS/Sham) on mood state was
assessed using a Mood Change difference score calculated by
deducting the total score for positive affect/well-being prior to
stimulation from the total score after stimulation: Mood Change
= Mood scorePost Stimulation Mood scorePre Stimulation. A positive
score indicated an improvement in mood state after stimulationR (n = 30) ANOVA Group differences
17 F(2,83) = .142, p = .868 –
90 (6.6) F(2,83) = 382.668, p < .001*** YA < HOA/OVR
7 (1.9) F(2,83) = 1.590, p = .210 –
3 (4.4) F(2,83) = 3.437, p = .037* YA < HOA
17 (1.0) F(2,83) = 1.539, p = .221 –
9 (2.3) F(2,83) = 20.502, p < 001*** OVR > HOA/YA
.60 (6.9) F(2,83) = .710, p = .495 –
groups.
or other post 16 qualification; 3 = A Level/BTEC/Access course; 4 = Diploma/HND; 5
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stimulation. A repeated-measures ANOVA assessed Mood Change
across the whole participant sample across Stimulation conditions
(active-tRNS/Sham). Mixed model ANOVAs explored whether
Mood Change differed depending on Stimulation and Age (YA/
OA), and depending on Stimulation and Age/CVRF (YA/HOA/OVR).
A Bonferonni correction was applied to post hoc analyses to correct
for multiple comparisons.
To assess the effect of individual differences on response to
stimulation, separate multiple regression analyses were conducted
for PANAS-Positive and WEMWBS Mood Change scores. These
were performed for each sham and active-tRNS sessions using
the enter method to examine the relationship between Mood
Change and four potential predictors: Trait Mood (GDS), Age, FSRP
(%), and the interaction term Group  GDS score (YA  GDS; HOA
 GDS; OVR  GDS).3. Results
3.1. Demographics & GDS scores between sessions
3.1.1. Group differences
Participant groups were comparable in terms of sex, education
level, and cognition (MMSE, FSIQ). As expected, YA were signifi-
cantly younger than the HOA and OVR. Similarly, OVR demon-
strated significantly higher CVRF than YA and HOA when
quantified with the FSRP. YA had significantly lower trait mood
on the GDS compared HOA but not OVR participants, see Table 1.
GDS scores measuring trait mood did not differ significantly
between sessions for the whole sample (t(85) = 1.057, p = .293)
or each group; HOA (t(27) = .957, p = .347), OVR (t(29) = 1.092,
p = .284), or YA (t(27) = .429, p = .671). The relationship between
GDS score and baseline mood (positive affect and well-being scores
pre-stimulation) was also consistent across all groups in both
active-tRNS and sham sessions; HOA, OVR, and YAs showed a sig-
nificant negative correlation between GDS and baseline well-being,
and non-significant negative correlation between GDS and baseline
positive affect (data not shown).3.2. Effect of active-tRNS/sham on state mood
ANOVAs assessed whether tRNS improved positive affect/well-
being across the whole sample, and whether the effect of tRNS on
state mood differed depending on age (YA/OA) or presence of car-
diovascular risk factors (YA/HOA/OVR).3.2.1. PANAS-positive affect ANOVAs
Whole sample: repeated-measures ANOVA confirmed a
non-significant main effect of Stimulation (active-tRNS/sham)
indicating that change in positive affect was consistent between
active-tRNS (M = 1.29 ± 4.35) and sham (M = .85 ± 4.06) conditions
(F(1,85) = .611, p = .437, gp2 = .007).
YA and OA: mixed model ANOVA demonstrated non-significant
main effects for Stimulation (F(1,84) = .380, p = .539, gp2 = .005), Age
(F(1,84) = .443, p = .507, gp2 = .005), and interaction Stimulation 
Age (F(1,84) = .104, p = .748, gp2 = .001) indicating that Mood
Change was comparable for both YA and OA in both active-tRNS
and sham conditions.
YA, HOA, and OVR: non-significant main effects for Stimulation
(F(1,35) = .567, p = .453, gp2 = .007), Age/CVRF group (F(2,83) = .234,
p = .792, gp2 = .006), and interaction Stimulation  Age/CVRF
(F(2,83) = .199, p = .820, gp2 = .005) confirmed Mood Change did
not differ depending on stimulation condition, age or presence of
cardiovascular risk factors.3.2.2. WEMWBS ANOVAs
Whole sample: change in well-being was comparable between
active-tRNS (M = 1.40 ± 4.08) and sham (M = 1.44 ± 3.52) condi-
tions (F(1,85) = .008, p = .927, gp2 < .001) across all participants.
YA and OA: non-significant main effects of Stimulation (F(1,84) =
.017, p = .896, gp2 < .001), Age (F(1,84) = .446, p = .506, gp2 = .005),
and interaction Stimulation  Age (F(1,84) = .017, p = .896, gp2 <
.001) confirmed that well-being did not significantly differ depend-
ing on stimulation condition or age.
YA, HOA, and OVR:Mood Change did not differ depending on the
age of the participants or presence of cardiovascular risk factors as
demonstrated by non-significant main effects of Stimulation
(F(1,83) = .005, p = .943, gp2 < .001), Age/CVRF (F(2,83) = .237,
p = .790, gp2 = .006), and interaction Stimulation  Age/CVRF
(F(2,83) = .309, p = .735, gp2 = .007).
3.3. Effect of individual differences on mood change
Although non-significant effects of tRNS on Mood Change was
observed at a group level, regression analyses assessed whether
individual differences influenced participants response to tRNS.
These were performed for each sham and active-tRNS session
using the predictors age, trait mood (GDS), cardiovascular risk
(FSRP%), and interaction terms YA  GDS, HOA  GDS, and OVR
 GDS.
3.3.1. PANAS-positive affect regressions
Active-tRNS: the model significantly explained 14.4% of the vari-
ance in Mood Change (F(5,80) = 2.702, p = .026, R2 = .144, R2Adjusted =
.091) with the interaction terms YA  GDS (b = 2.450, t(80) =
2.596, p = .011) and HOA  GDS (b = 2.129, t(80) = 2.184, p = .032)
contributing significantly to the model. In YA, mood reduced by
2.45 points for each point on the GDS; the lower trait mood – the
greater negative change in mood state after active-tRNS. In HOA,
mood increased by 2.18 with each point on the GDS; the lower trait
mood – the more positive change in mood state after active-tRNS.
Age, GDS, FSRP, and OVR  GDS did not contribute significantly to
the model (p  .219). Fig. 1 indicates that both HOA and OVR demon-
strate a similar association between Mood Change after tRNS and
GDS.
Sham: the model did not significantly explain any variance
in Mood Change after sham (F(5,80) = .738, p = .597, R2 = .044,
R2Adjusted = .016).
Including baseline state mood: to confirm that baseline state
mood was not driving the results, positive affect score pre-
stimulation was included as an additional predictor. Results con-
firmed that baseline state mood did not significantly contribute
to either model. During active-tRNS, the model significantly
explained 14.4% of the variance in Mood Change (F(6,79) = 2.275,
p = .045, R2 = .147, R2Adjusted = .083). During sham, the model did
not significantly explain variance in Mood Change (F(6,79) = .644,
p = .695, R2 = .047, R2Adjusted = .026).
3.3.2. WEMWBS regressions
Active-tRNS: the model significantly explained 16.8% of the
variance in well-being change (F(5,80) = 3.241, p = .010, R2 = .168,
R2Adjusted = .116); the interaction term YA  GDS (b = 2.941, t(80) =
3.370, p = .001) contributed to the model. In YA, mood reduced
by 2.94 points for each point on the GDS. The lower trait mood
scores, the greater the negative change in mood state after tRNS.
Age, GDS, FSRP, HOA  GDS, and OVR  GDS did not contribute
significantly to the model (p  .194).
Sham: Variance in Mood Change after sham stimulation was
not significantly explained by the model (F(5,80) = 1.434, p = .221,
R2 = .082, R2Adjusted = .025).
Fig. 1. A: PANAS-positive Mood Change after active-tRNS (left) and after Sham (right) in relation to GDS scores across all participant groups (YA/HOA/OVR). B: WEMWBS
Mood Change after active-tRNS (left) and after Sham (right) in relation to GDS scores across all participant groups. For Mood Change a positive score indicated positive change
in mood and a negative score indicated a negative change in mood. More positive GDS scores indicate more negative general mood and more negative GDS scores indicate
more positive general mood.
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pre-stimulation as an additional predictor confirmed that baseline
state mood did not significantly contribute to either model.
During active-tRNS, the model significantly explained 17.0% of
the variance in Mood Change (F(6,79) = 2.687, p = .020, R2 = .170,
R2Adjusted = .103), whereas during sham, the model did not signifi-
cantly explain variance in Mood Change (F(6,79) = 1.183, p = .324,
R2 = .082, R2Adjusted = .013).4. Discussion
This study examined the efficacy of tRNS to improve mood and
whether this differs depending on individual differences in euthy-
mic younger and older adults with and without CVRF. Results from
two measures (PANAS-positive affect & WEMWBS) indicated that
active-tRNS did not improve positive affect or well-being across
all participants or within each participant group (YA/HOA/OVR),suggesting that tRNS was not sufficient in facilitating greater pos-
itive mood than a positive memory mood induction alone. Notably
however, the patterns of response to active-tRNS appeared to differ
depending on individual differences in age and trait mood. A small
but significant proportion of the variance in positive affect after
active-tRNS was explained by interaction terms for trait mood in
the YA and HOA group. This trend was also observed for well-
being, where the interaction term of trait mood and YA group
reached significance. These results suggest that age and trait mood
may be important variables affecting the efficacy of tES and are in
line with a growing body of research emphasising the role of indi-
vidual differences on the effect of stimulation.
Among older adults, individuals with lower trait mood reported
the most positive change in mood after active-tRNS stimulation.
This association was significant when mood was measured in
terms of positive affect but did not reach significance for well-
being. The relationship between trait mood and mood change after
active-tRNS is positive and in keeping with some of the tDCS
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This relationship, whereby HOA at most risk may show the greatest
benefit, also follows a similar pattern to previous studies of tDCS
applied to improve cognitive performance, where a relationship
between baseline performance and response to stimulation has
been observed (Berryhill and Jones, 2012; Learmonth et al.,
2015). One explanation for these results is that those with the low-
est mood have the greatest capacity for positive change. However,
as the scores on all measures were not at ceiling for any group, all
participants could have reported positive change in mood.
Although the overall positive trait mood ratings were higher in
the HOA group compared to YA, GDS scores alone did not signifi-
cantly contribute to explaining the variance in tRNS response, sug-
gesting that additional factors including age are influencing the
effects of tRNS on mood. Coupled with the non-significant effect
of tRNS on mood observed at a group level, the influence of age
and trait mood on response to tRNS emphasises the importance
of examining how individual differences may impact the efficacy
of tES as a treatment for depression.
Whilst HOA with poorer trait mood showed the most positive
change after tRNS, YA displayed the opposite pattern. In the cur-
rent euthymic YA sample, applying tRNS bilaterally to DLPFC
seemed to reduce mood state in those with lowest trait mood for
both mood measures, positive affect and well-being. Yet, YA
reporting more positive trait mood showed greater positive
change. This pattern of results differs to previous studies that have
shown reduced depressive symptoms in young adults with MDD
when applying 1–2 mA of tDCS to the left DLPFC for approximately
20 min (Boggio et al., 2008; Ferrucci et al., 2009; Pérez et al., 2016).
It is possible that the relationship between tRNS and mood
change in this euthymic adult sample is due to the use of bilateral
DLPFC tRNS, which contrasts previous studies of young adults and
those described here. For YA bilateral DLPFC tRNS could intensify
the trait mood of the individual, therefore stimulation could be
positive or negative depending on current mood (Feeser et al.,
2014; Möbius et al., 2017). Due to reduced task-specific hemi-
spheric asymmetry observed in older adults (Cabeza, 2002), bilat-
eral stimulation was selected in an attempt to optimise the
protocol for older adults. The relationship between trait mood
and positive effects of tRNS observed in HOA in the current study
support this theory. However it is important to note that it may
be detrimental to young adults who do not typically rely on bilat-
eral activation (Herrington et al., 2005). Bilateral tRNS to the DLPFC
may have a different mechanism and effects compared to anodal
tDCS over the left DLPFC (the most commonly used stimulation
protocol). Only one previous case study in a 35-year-old woman
with depression has demonstrated improvements in mood using
bilateral DLPFC tRNS, although the cathode electrode was placed
over F8 rather than F4 (Chan et al., 2012). The optimum stimula-
tion protocol may therefore differ between younger and older
adults.
As well as bilateral stimulation potentially having differing
effects on younger and older adult populations, the effects of tRNS
in this euthymic sample may be due to differences in the severity
of depressive symptoms. However the regression model suggests
that it is the interaction between depressive symptoms and age
that is important. It is also worth noting that all groups described
here reported normal mood levels and the effects of tRNS may dif-
fer in MDD or late-life depression. High-frequency tRNS may be
most effective for improving mood in severe low mood where cri-
teria for MDD are met. Research by Nitsche et al. (2012) suggest
the effect of tDCS may be limited to emotion processing and not
self-reported mood in healthy participants. Nevertheless, facilita-
tory effects have been noted elsewhere in the literature when
using tDCS in healthy populations. TDCS has been shown to
facilitate cognitive reappraisal both positively and negativelydepending on the regulatory goal (Feeser et al., 2014). Although
not a study of mood per se, Boggio and colleagues (Boggio et al.,
2009) also demonstrated that healthy young adults reported less
‘‘unpleasantness” when viewing aversive stimuli, suggesting that
lower mood is not necessary for tES to have an elevatory effect.
It is worth noting that studies in MDD have reported mixed results,
with some studies not demonstrating improvements in mood after
tDCS (Nitsche et al., 2012; Palm et al., 2012), so other factors apart
from depressive symptoms may influence response to stimulation
(Loo et al., 2012).
One major issue raised by these results is the suggestion that
individual differences including age and the level of depressive
symptoms as well as interactions between such factors may influ-
ence response to tES for the elevation of mood. This is an important
consideration for future studies using tES to modulate mood, as it
highlights the importance of individual differences which may
need careful consideration to optimise stimulation outcomes
(Fertonani et al., 2016). Inter-individual differences in neurophys-
iology, anatomy, and psychology have been reported to result in
substantial within- and between-group variances in response to
tDCS (for reviews see Horvath et al., 2014; Krause and Cohen
Kadosh, 2014). Though speculative, results suggest that individual
differences may explain response to tES even in the absence of dif-
ferences at the group level; when inter-individual variability can
result in a different or even opposing response to tES, regressing
to the mean of the sample may collapse any effect of tES that is
occurring at an individual level. Another issue raised by the dis-
crepancy in mood change across YA and HOA is the need to explore
the anatomical specificity of these effects by comparing mood
change across different electrode montages including stimulation
of unilateral or bilateral DLPFC, and a control site. This was not
explored in the current study as the focus was on individual differ-
ences and the efficacy of tRNS.
Another purpose of this study was to examine the effects of car-
diovascular risk on response to tRNS in ageing. There were no sig-
nificant differences between response to tRNS in the HOA
compared to the OVR group, although the magnitude of the effect
were lower in OVR. Although preliminary, the comparable rela-
tionship between age, trait mood, and response to tRNS suggest
that tRNS may be as efficacious in OVR as in HOA. It is worth noting
however that the OVR group described here does not include sev-
ere cardiovascular disease such as stroke, transient ischaemic
attacks, or chronic obstructive pulmonary disease. Only one indi-
vidual had diabetes (an additional participant was borderline),
and 13 had diagnosed hypertension, with most individuals control-
ling their CVRF through diet and medication. Thus it remains to be
established if the pattern reported here in individuals with rela-
tively mild CVRF is comparable with more severe or uncontrolled
cardiovascular disease. TRNS efficacy may reduce with severity of
cardiovascular disease due to severity of damage in brain and dis-
ruption of neural networks (Alexopoulos, 2005). A limitation of this
study was the lack of information about cardiovascular damage in
the brain among older adults. Although one commonly observes
strong associations between CVRF and cardiovascular damage in
brain, individual differences do occur (Charlton et al., 2014). Future
studies should aim to quantify cardiovascular damage in brain to
fully explore the effect of cardiovascular disease on tES. This is par-
ticularly important if treatment controlled cardiovascular disease
reduces the commonly associated cardiovascular damage.
It is important to acknowledge a number of study limitations
that may also help understand the results observed in the current
study. In the tRNS protocol, individuals received stimulation in a
single session, which has been argued to be insufficient to affect
mood in euthymic participants (for review see Remue et al.,
2016). Mood was measured using self-report measures, which
may be relatively insensitive to small changes in mood; using a
C. Evans et al. / Clinical Neurophysiology 129 (2018) 1201–1208 1207more objective measure (for example galvanic skin response, heart
rate, etc) may be more sensitive to detecting changes. It is also fea-
sible that multiple sessions may result in additive benefits that
would be observable across each population at a group level.
Although it is to be noted that our knowledge of how multiple ses-
sions of stimulation contribute to interactions between cortical
excitability and behaviour remains unclear (Batsikadze et al.,
2013). Further, work in other domains shows that a single session
of tRNS is sufficient to modulate behavioural outcomes at least
temporarily (e.g. Romanska et al., 2015). In this study we were cau-
tious of the deleterious effects of overstimulation, especially in an
under-investigated group of older adults where the impact of age-
related brain changes is unknown (Batsikadze et al., 2013; Nitsche
and Paulus, 2011). Since this single-session protocol did not consis-
tently improve mood across our participant groups, future studies
may target repeated tRNS using this protocol or explore the effi-
cacy of other levels of stimulation. As mood was measured imme-
diately after stimulation sessions, any longer term effects of
stimulation could not be observed. A longer follow-up would be
required to examine the duration of effects. Studies of the effect
of an intervention may also suffer from placebo effects, particularly
when coupled with a positive mood induction (recall of positive
memories in this instance). However the use of a double-blind
design, tRNS with its low cutaneous effects, and both stimulation
and sham sessions for participants should reduce any likely pla-
cebo effect.
The current study examined the efficacy of tRNS of the DLPFC to
elevate mood in euthymic older and YAs. Whilst tRNS did not sig-
nificantly improve mood across participants, response to tRNS
seemed to depend on individual differences in age and trait mood.
In HOA, more negative trait mood was associated with a greater
positive mood change after tRNS. OVR showed a similar but
reduced pattern of mood change to HOA, suggesting that mild
CVRF may not overly disrupt tES effects. In YA, more positive trait
mood was associated with greater positive mood change after
tRNS, results may suggest an enhancement of current mood
(whether positive or negative) after stimulation in YA. Age, trait
mood and their interaction may be important factors when exam-
ining the efficacy of tES. Future studies should consider how indi-
vidual differences interact with tES and affect response to
stimulation.
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